Biogen Inc (BIIB) Event July 20, 2022, 11:04 UTC 24 1 comments (10% Negative) BIOGEN INC. (BIIB) Reports Q3 2022 Financial Results Comment Full text
RPID Event July 20, 2022, 10:59 UTC 104 0 comments New On-Demand Webinar Now Available Comment Full text
Exelixis Inc (EXEL) Event July 19, 2022, 21:28 UTC 25 1 comments (99% Neutral) EXELIXIS, INC. (EXEL) Announces Regulatory Update Comment Full text
BioNTech SE (BNTX) Event July 19, 2022, 21:12 UTC 21 1 comments (85% Positive) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K) Comment Full text
Aquestive Therapeutics Inc (AQST) Event July 19, 2022, 20:46 UTC 24 1 comments (99% Neutral) Aquestive Therapeutics, Inc. (AQST) Announces New Board Appointment Comment Full text
Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Event July 19, 2022, 20:06 UTC 24 1 comments (99% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Files Form 8-K Comment Full text
Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Event July 19, 2022, 20:03 UTC 23 1 comments (99% Neutral) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K Comment Full text
Inovio Pharmaceuticals Inc (INO) Event July 19, 2022, 12:53 UTC 24 1 comments (90% Positive) Inovio Pharmaceuticals, Inc. (INO) Announces Clinical Development Update Comment Full text
Alpine Immune Sciences Inc (was acquired Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) on 10/04/2024) (ALPN) Event July 19, 2022, 12:21 UTC 26 1 comments (10% Negative) ALPINE IMMUNE SCIENCES, INC. (ALPN) Files Form 8-K Comment Full text
Genmab (GMAB) Event July 19, 2022, 12:14 UTC 23 1 comments (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text